Seelos Therapeutics

SEEL · Other

$0.00−$0.0001 (−90.00%)TodayMarket closed ·
No price history for this range.

Key indicators

SEEL profitability and balance sheet ratios

EPS $0.6798 in Jun 2024, against -$53.67 a year earlier.

EPS by quarter
PeriodEPS
Sep 2022-$44.10
Dec 2022-$41.82
Mar 2023-$28.65
Jun 2023-$53.67
Sep 2023$17.01
Dec 2023-$6.29
Mar 2024-$1.64
Jun 2024$0.6798

Income statement

No financial statements are reported for Seelos Therapeutics.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.